[Corrigendum] Influence of MLH1 on colon cancer sensitivity to poly(ADP‑ribose) polymerase inhibitor combined with irinotecan
Following the publication of the above article, an interested reader drew to the attention of the Editorial Office that the immunofluorescence images shown in Fig. 3B on p. 214 to represent the 'HCT116 SiP' and 'HCT116+3 SiP' experiments (top row of data) were strikingly similar. Upon examining their data, the authors have realized that the data in Fig. 3B were presented incorrectly; specifically, the data shown in the 'HCT116+3 SiP' panel were erroneously duplicated from the data shown correctly in the 'HCT116 SiP' panel. The authors have now submitted a revised version of Fig. 3, containing the corrected version of the 'HCT116+3 SiP' data panel in Fig. 3B, and this is shown on the next page. Note that this error did not affect the overall conclusions reported in the study. The authors are grateful to the Editor of <i>International Journal of Oncology</i> for allowing them this opportunity to publish a Corrigendum, and all the authors agree with its publication. Furthermore, the authors apologize to the readership for any inconvenience caused. [International Journal of Oncology 43: 210‑218, 2013; DOI: 10.3892/ijo.2013.1932].
Authors
- Federica Campolo (ORCID: https://orcid.org/0000-0002-9290-874X)
- Alessia Muzi (ORCID: https://orcid.org/0000-0001-6946-3888)
- Manuela Porru (ORCID: https://orcid.org/0000-0002-6614-9110)
- Susanna Dolci (ORCID: https://orcid.org/0000-0002-6864-3673)
- Lucio Tentori (ORCID: https://orcid.org/0000-0002-7691-527X)
- Annalisa Susanna Dorio
- Patrizia Vernole
- Françoise Praz
- Carlo Leonetti
- Pedro Lacal
- Grazia Graziani
Institutions
- University of Rome Tor Vergata (IT)
- Inserm (FR)
- Istituto Dermopatico dell'Immacolata (IT)
- Centre de Recherche Saint-Antoine (FR)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- International Journal of Oncology
- Published
- 2026-03-09
- DOI
- https://doi.org/10.3892/ijo.2026.5868
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00